Verition Fund Management
ORGO icon

Verition Fund Management’s Organogenesis Holdings ORGO Stock Holding History

Verition Fund Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-78,690
Closed -$225K – 3440
2024
Q3 		$225K Buy
78,690
+66,448
+543% +$186K ﹤0.01% 2813
2024
Q2 		$34.3K Sell
12,242
-4,578
-27% -$12.3K ﹤0.01% 2829
2024
Q1 		$47.8K Buy
+16,820
New +$57.2K ﹤0.01% 2640
2023
Q2 		– Sell
-66,150
Closed -$141K – 2444
2023
Q1 		$141K Buy
+66,150
New +$163K ﹤0.01% 1856
2021
Q3 		– Sell
-38,163
Closed -$635K – 2205
2021
Q2 		$635K Buy
+38,163
New +$711K 0.01% 986

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's ORGO Position: Q4 2024 in Review

Verition Fund Management sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 78,690 shares — an estimated $225K sold.

Verition Fund Management first reported a position in ORGO in Q2 2021 and held it in 5 quarters. The position peaked at $635K in Q2 2021. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Verition Fund Management reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 78,690 Organogenesis Holdings shares in Q4 2024, an estimated $225K.
  • Verition Fund Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 5 quarters.
  • Verition Fund Management's Organogenesis Holdings position peaked at $635K in Q2 2021.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.